Medivation Aktie

Medivation für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: A0ETXH / ISIN: US58501N1019

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
22.08.2016 19:45:00

Wyeth -- Moody's affirms Pfizer at A1/P-1; outlook remains negative

New York, August 22, 2016 -- Moody's Investors Service affirmed the ratings of Pfizer Inc. and related subsidiaries, including the A1 senior unsecured long-term rating and the Prime-1 commercial paper rating. The rating outlook remains negative. This action follows the announcement that Pfizer will acquire Medivation, Inc. (unrated) for approximately $14 billion.

Vollständigen Artikel bei Moodys lesen